Not only is TBI associated with an increased risk of AD, but both pathologies share characteristic histopathological features: amyloidosis, p-tau aggregation, chronic inflammation and oxidative stress all play a critical role in mediating neurodegeneration and cognitive decline in both conditions, albeit following different spatial and temporal evolution patterns. Here, MAPT is linked to amyloidosis.